StockMacro
Menu

Robert Andrade

Insider (Form 4 reporting owner): CHIEF FINANCIAL OFFICER CIK 1468308Name as filed: Andrade RobertIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 28 Dec 2022, sold $1.9M in 6 sales (4 under a 10b5-1 plan set in advance) of Fennec Pharmaceuticals.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Fennec Pharmaceuticals FENCCHIEF FINANCIAL OFFICER28 Dec 202227 Aug 2026–6$1.9M

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After salestoo few trades4 tradestoo few trades4 tradestoo few trades4 trades

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2026––1$884K-$884K
2024––3$622K-$622K
2023––1$223K-$223K
2022––1$211K-$211K

Every trade

7, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
27 Aug 2026Fennec Pharmaceuticals FENCSellafter exercising options75,000$11.78$884K10b5-1 planForm 4filed 28 Aug 2026
1 Apr 2024Fennec Pharmaceuticals FENCBuyprice as filed looks wrong; not counted0Not filedNot filedNoForm 4filed 3 Apr 2024
26 Mar 2024Fennec Pharmaceuticals FENCSell13,975$10.90$152KNoForm 4filed 27 Mar 2024
25 Mar 2024Fennec Pharmaceuticals FENCSell13,975$11.00$154K10b5-1 planForm 4filed 25 Mar 2024
4 Jan 2024Fennec Pharmaceuticals FENCSell30,000$10.53$316K10b5-1 planForm 4filed 5 Jan 2024
28 Jun 2023Fennec Pharmaceuticals FENCSellafter exercising options25,000$8.93$223K10b5-1 planForm 4filed 30 Jun 2023
28 Dec 2022Fennec Pharmaceuticals FENCSell22,000$9.60$211KNot statedForm 4filed 30 Dec 2022

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.